Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TRANSGENE BI vs CONSTRONICS INFRA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TRANSGENE BI CONSTRONICS INFRA TRANSGENE BI/
CONSTRONICS INFRA
 
P/E (TTM) x -183.7 86.3 - View Chart
P/BV x 4.5 164.8 2.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 TRANSGENE BI   CONSTRONICS INFRA
EQUITY SHARE DATA
    TRANSGENE BI
Mar-24
CONSTRONICS INFRA
Mar-24
TRANSGENE BI/
CONSTRONICS INFRA
5-Yr Chart
Click to enlarge
High Rs1245 27.5%   
Low Rs25 45.9%   
Sales per share (Unadj.) Rs01.1 2.9%  
Earnings per share (Unadj.) Rs-0.11.0 -8.7%  
Cash flow per share (Unadj.) Rs-0.11.0 -7.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs1.41.3 105.6%  
Shares outstanding (eoy) m75.777.21 1,050.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x238.823.5 1,014.9%   
Avg P/E ratio x-85.625.4 -337.5%  
P/CF ratio (eoy) x-99.624.4 -408.5%  
Price / Book Value ratio x5.218.8 27.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m561182 308.7%   
No. of employees `000NANA-   
Total wages/salary Rs m31 252.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m28 30.4%  
Other income Rs m25 37.3%   
Total revenues Rs m413 33.1%   
Gross profit Rs m-63 -189.4%  
Depreciation Rs m10 317.2%   
Interest Rs m10 1,400.0%   
Profit before tax Rs m-78 -85.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m01 0.0%   
Profit after tax Rs m-77 -91.5%  
Gross profit margin %-258.041.4 -622.8%  
Effective tax rate %07.1 -0.0%   
Net profit margin %-278.992.7 -300.9%  
BALANCE SHEET DATA
Current assets Rs m1159 18.9%   
Current liabilities Rs m1111 10,221.1%   
Net working cap to sales %-4,268.8743.0 -574.5%  
Current ratio x0.153.7 0.2%  
Inventory Days Days206,570272 75,819.2%  
Debtors Days Days130262 49.8%  
Net fixed assets Rs m1,4127 19,478.8%   
Share capital Rs m75872 1,051.0%   
"Free" reserves Rs m-651-62 1,041.9%   
Net worth Rs m10710 1,110.2%   
Long term debt Rs m5155 92.4%   
Total assets Rs m1,42366 2,163.7%  
Interest coverage x-3.778.1 -4.7%   
Debt to equity ratio x0.55.7 8.3%  
Sales to assets ratio x00.1 1.4%   
Return on assets %-0.411.0 -3.3%  
Return on equity %-6.174.2 -8.2%  
Return on capital %-3.312.1 -27.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m0-2 -2.9%  
From Investments Rs mNA-5 -0.0%  
From Financial Activity Rs mNA53 0.0%  
Net Cashflow Rs m046 0.1%  

Share Holding

Indian Promoters % 23.6 10.6 222.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 89.4 85.4%  
Shareholders   12,963 3,707 349.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TRANSGENE BI With:   APOLLO HOSPITALS    NARAYANA HRUDAYALAYA    DR. LAL PATHLABS    KIMS    METROPOLIS HEALTHCARE    


More on TRANSGENE BI vs INNOVATION MEDICAL

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

TRANSGENE BI vs INNOVATION MEDICAL Share Price Performance

Period TRANSGENE BI INNOVATION MEDICAL
1-Day -1.54% -4.62%
1-Month -11.48% 3.63%
1-Year -22.80% 805.49%
3-Year CAGR 20.04% 136.23%
5-Year CAGR 20.30% 95.81%

* Compound Annual Growth Rate

Here are more details on the TRANSGENE BI share price and the INNOVATION MEDICAL share price.

Moving on to shareholding structures...

The promoters of TRANSGENE BI hold a 23.6% stake in the company. In case of INNOVATION MEDICAL the stake stands at 10.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TRANSGENE BI and the shareholding pattern of INNOVATION MEDICAL.

Finally, a word on dividends...

In the most recent financial year, TRANSGENE BI paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

INNOVATION MEDICAL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of TRANSGENE BI, and the dividend history of INNOVATION MEDICAL.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.